Herold Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$211K 279
2024
Q3
$211K Buy
+1,000
New +$174K 0.05% 256
2024
Q2
Sell
-1,000
Closed -$215K 272
2024
Q1
$215K Hold
1,000
0.05% 246
2023
Q4
$203K Buy
+1,000
New +$162K 0.06% 234
2023
Q3
Sell
-1,000
Closed -$325K 253
2023
Q2
$325K Hold
1,000
0.1% 190
2023
Q1
$234K Hold
1,000
0.08% 206
2022
Q4
$252K Buy
+1,000
New +$213K 0.11% 177
2022
Q2
Sell
-1,000
Closed -$257K 406
2022
Q1
$257K Hold
1,000
0.09% 178
2021
Q4
$230K Hold
1,000
0.09% 183
2021
Q3
$232K Buy
+1,000
New +$209K 0.09% 179

Other funds holding INSP

Herold Advisors's INSP Position: Q4 2024 in Review

Herold Advisors sold out of Inspire Medical Systems (INSP) in Q4 2024, closing a stake of 1,000 shares — an estimated $211K sold.

Herold Advisors first reported a position in INSP in Q3 2021 and held it in 9 quarters. The position peaked at $325K in Q2 2023. 357 funds tracked by Wall St. Rank hold INSP as of Q4 2024.

  • Herold Advisors reported no remaining Inspire Medical Systems position as of Q4 2024 after selling out during the quarter.
  • Herold Advisors sold 1,000 Inspire Medical Systems shares in Q4 2024, an estimated $211K.
  • Herold Advisors first reported a position in Inspire Medical Systems in Q3 2021 and held it in 9 quarters.
  • Herold Advisors's Inspire Medical Systems position peaked at $325K in Q2 2023.
  • 357 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2024.

Based on Herold Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.